# FDA Inspection 1261728 - Braintree, A part of SEBELA Pharmaceuticals - March 07, 2025

Source: https://www.globalkeysolutions.net/records/fda_inspections/braintree-a-part-of-sebela-pharmaceuticals/2f230059-8323-442e-8b68-dd71d065676a
Source feed: FDA_Inspections

> FDA Inspection 1261728 for Braintree, A part of SEBELA Pharmaceuticals on March 07, 2025. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1261728
- Company Name: Braintree, A part of SEBELA Pharmaceuticals
- Inspection Date: 2025-03-07
- Product Type: Human Drugs
- Office Name: New England District Office

## Related Documents

- [FDA Inspection 1261728 - 2025-03-07](https://www.globalkeysolutions.net/records/fda_inspections/braintree-a-part-of-sebela-pharmaceuticals/4b903c68-595f-4b48-a387-1c742007f850)
- [FDA Inspection 1042622 - 2018-02-28](https://www.globalkeysolutions.net/records/fda_inspections/braintree-a-part-of-sebela-pharmaceuticals/717fe323-8916-49e3-b346-16040875b8a5)
- [FDA Inspection 858979 - 2013-12-13](https://www.globalkeysolutions.net/records/fda_inspections/braintree-a-part-of-sebela-pharmaceuticals/c3a1df7e-8ea7-46ac-bef1-11ec0e804d15)
- [FDA Inspection 814842 - 2013-01-14](https://www.globalkeysolutions.net/records/fda_inspections/braintree-a-part-of-sebela-pharmaceuticals/fe3f162e-f53a-4d65-a540-7b3c69967bc8)
- [FDA Inspection 707123 - 2011-01-21](https://www.globalkeysolutions.net/records/fda_inspections/braintree-a-part-of-sebela-pharmaceuticals/2980d372-45f6-4f29-bbd3-a2e16a160b75)

Company: https://www.globalkeysolutions.net/companies/braintree-a-part-of-sebela-pharmaceuticals/e32fa961-98ff-4606-8883-8c382bf240e2

Office: https://www.globalkeysolutions.net/offices/new-england-district-office/aa458072-2f1d-4231-89f5-21ba7a3b7144